{"meta":{"query_hash":"5b4edef27fa5","filters":{"venue":"European Neurological Review"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5b4edef27fa5","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Neurological+Review"},"results":[{"id":"W2183127476","doi":"10.17925/enr.2012.07.01.28","title":"Deep Brain Stimulation for Parkinson’s Disease - A Review","year":2012,"lang":"en","type":"review","venue":"European Neurological Review","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders; University of British Columbia","funders":"","keywords":"Deep brain stimulation; Dyskinesia; Medicine; Parkinson's disease; Intervention (counseling); Motor symptoms; Disease; Refractory (planetary science); Medical therapy; Physical medicine and rehabilitation; Intensive care medicine; Physical therapy; Psychiatry; Surgery; Internal medicine","score_opus":0.12698532006275248,"score_gpt":0.37837185007707724,"score_spread":0.25138653001432476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183127476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005616401,0.9994461,0.0000334218,0.000058260204,0.00007248823,0.0000041666854,0.000009062519,0.0000024278972,0.00031789232],"genre_scores_gemma":[0.0003582198,0.9992489,0.000099129655,0.00006392435,0.00005620045,0.0000050144067,0.000013660267,7.319735e-7,0.00015411919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997607,0.00004349835,0.00006658304,0.000036987152,0.000077793586,0.00001432933],"domain_scores_gemma":[0.99959165,0.00023278175,0.000078414094,0.0000092557675,0.000068372334,0.000019463829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055160996,0.0011249728,0.001691514,0.0029674175,0.0002943074,0.00093590724,0.0009753169,0.0009408201,0.0048806164],"category_scores_gemma":[0.0009902966,0.00030389856,0.0006910148,0.0039320705,0.00039757622,0.001303913,0.00059753464,0.0011045471,0.0018484092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006551691,0.00008115334,0.00014274757,0.06850643,0.00017710954,0.00033624552,0.000071486764,0.0002667415,0.0008523575,0.0012129453,0.02404233,0.90424484],"study_design_scores_gemma":[0.000054429245,0.00018056051,0.0020798352,0.04954331,0.0007300562,0.0056340825,0.00017451275,0.00012428148,0.00046372548,0.0018096237,0.9391662,0.000039356906],"about_ca_topic_score_codex":0.0014666931,"about_ca_topic_score_gemma":0.0026994632,"teacher_disagreement_score":0.0048806164,"about_ca_system_score_codex":0.0005284094,"about_ca_system_score_gemma":0.0012554786,"threshold_uncertainty_score":0.016327262},"labels":[],"label_agreement":null},{"id":"W2398521763","doi":"10.17925/enr.2013.08.02.130","title":"Symptomatic Treatment in Multiple Sclerosis","year":2013,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Multiple sclerosis; Spasticity; Depression (economics); Quality of life (healthcare); Disease; Physical medicine and rehabilitation; Gait; Physical therapy; Balance (ability); Activities of daily living; Psychiatry; Internal medicine","score_opus":0.17292346520806973,"score_gpt":0.3231499066670848,"score_spread":0.1502264414590151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398521763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017651394,0.9939237,0.00017951672,0.0004937391,0.0002510942,0.000016102405,0.000026163518,0.000012281202,0.0033321364],"genre_scores_gemma":[0.034660805,0.9608465,0.0007418981,0.0013181842,0.0005407243,0.000064178035,0.0001151844,0.0000063602824,0.0017062019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999795,0.00007528359,0.00002961465,0.000021597678,0.000062151295,0.00001649],"domain_scores_gemma":[0.99985504,0.00006807295,0.000034270673,0.000004090871,0.000026080408,0.0000123493555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003576272,0.00030407362,0.0007784301,0.00072575134,0.0002813661,0.00046704008,0.0003900526,0.0006828842,0.0036072517],"category_scores_gemma":[0.00056735595,0.00007084124,0.00042148834,0.0005702046,0.00021597867,0.00031859614,0.00031765533,0.00074829033,0.0007681553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036211932,0.00020174053,0.0003342882,0.023313811,0.00017605322,0.00062787987,0.00015703405,0.00010251451,0.0043928474,0.0019151436,0.021913059,0.9465035],"study_design_scores_gemma":[0.0008701505,0.0021522513,0.014256654,0.029744925,0.0009407655,0.017422846,0.0003683738,0.00023525578,0.0038717212,0.0049368334,0.92514896,0.00005132422],"about_ca_topic_score_codex":0.00047151267,"about_ca_topic_score_gemma":0.001078078,"teacher_disagreement_score":0.0036072517,"about_ca_system_score_codex":0.00028938617,"about_ca_system_score_gemma":0.0004205616,"threshold_uncertainty_score":0.012067437},"labels":[],"label_agreement":null},{"id":"W2476064101","doi":"10.17925/enr.2009.04.02.29","title":"The Effect of Non-motor Symptoms on Quality of Life in Parkinson's Disease","year":2009,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of New Brunswick","funders":"","keywords":"Medicine; Parkinson's disease; Motor symptoms; Quality of life (healthcare); Disease; Affect (linguistics); Pediatrics; Physical medicine and rehabilitation; Physical therapy; Psychiatry; Internal medicine; Psychology","score_opus":0.025012203799490835,"score_gpt":0.31378410860621886,"score_spread":0.28877190480672804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476064101","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065753483,0.9910082,0.00006960533,0.00060779945,0.00008669169,0.0000050312274,0.00003195767,0.0000026611374,0.0016127329],"genre_scores_gemma":[0.09302813,0.9052659,0.00035714416,0.0004322275,0.00021123487,0.000020679403,0.00006529899,0.000002008406,0.00061728613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994185,0.0002928961,0.00007606799,0.000031377873,0.00014660701,0.000034632514],"domain_scores_gemma":[0.9993125,0.00040218036,0.00013505295,0.000007520044,0.000104794766,0.00003791309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012203208,0.00030697943,0.0008254538,0.00060908665,0.00012714641,0.00048191904,0.0002820182,0.00038773718,0.0010931169],"category_scores_gemma":[0.0013883171,0.000076024575,0.0004938264,0.00066095754,0.00025847473,0.00029704033,0.00026262138,0.00041322413,0.00018520685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048934045,0.00011658836,0.012013381,0.016794752,0.0008463233,0.000655721,0.00032934357,0.00051860104,0.0012013593,0.0011080157,0.010156341,0.95577025],"study_design_scores_gemma":[0.00036930924,0.0045289644,0.53640544,0.0256526,0.0032919252,0.01786201,0.0017183495,0.0009527809,0.0031019489,0.0049965777,0.40098655,0.00013345062],"about_ca_topic_score_codex":0.0010278564,"about_ca_topic_score_gemma":0.002197272,"teacher_disagreement_score":0.0012203208,"about_ca_system_score_codex":0.00054559845,"about_ca_system_score_gemma":0.0003748478,"threshold_uncertainty_score":0.0064537525},"labels":[],"label_agreement":null},{"id":"W2479037164","doi":"10.17925/enr.2011.06.03.161","title":"Advances in the Role of Neuroimaging to Monitor Disease Progression in Parkinson’s Disease","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche sur Alzheimer; Michael Smith Health Research BC; Teva Pharmaceutical Industries","keywords":"Positron emission tomography; Neuroimaging; Medicine; Parkinson's disease; Neuroscience; Functional imaging; Dopaminergic; Putamen; Biomarker; Disease; Functional neuroimaging; Emission computed tomography; Imaging biomarker; Cerebral blood flow; Pet imaging; Dopamine; Pathology; Internal medicine; Magnetic resonance imaging; Psychology; Radiology; Biology","score_opus":0.035431052390475025,"score_gpt":0.3108085070481553,"score_spread":0.2753774546576803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479037164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024621754,0.984046,0.0045420895,0.0044355523,0.00035527095,0.000025798947,0.000048272606,0.00004163256,0.0040432443],"genre_scores_gemma":[0.031314712,0.9463154,0.017472932,0.0014671537,0.002258409,0.00006427672,0.000050645307,0.000016482112,0.0010399114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843615,0.0008154357,0.00012784812,0.00023223233,0.00033959755,0.00004879725],"domain_scores_gemma":[0.9945956,0.0036136697,0.00044998393,0.00017166966,0.0010514027,0.00011772282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006940761,0.00089227036,0.0015147525,0.0025017217,0.0002183068,0.001250609,0.0011055439,0.0018459652,0.0011363951],"category_scores_gemma":[0.006018165,0.0002654666,0.0004644826,0.0014158444,0.0012260281,0.0017334941,0.0006264237,0.0014697543,0.0004507139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015184899,0.000094045674,0.005034063,0.0031108742,0.00013489329,0.00034242336,0.0001394818,0.0005617476,0.003181342,0.0055209096,0.00643524,0.9752931],"study_design_scores_gemma":[0.00014297804,0.0015652209,0.0707178,0.007422419,0.0009066383,0.015827306,0.00070190255,0.0050482866,0.007652706,0.035826966,0.8539296,0.0002581643],"about_ca_topic_score_codex":0.002078901,"about_ca_topic_score_gemma":0.0024852785,"teacher_disagreement_score":0.006940761,"about_ca_system_score_codex":0.00081297144,"about_ca_system_score_gemma":0.001135304,"threshold_uncertainty_score":0.036706746},"labels":[],"label_agreement":null},{"id":"W2480287584","doi":"10.17925/enr.2009.04.01.36","title":"Population-based Studies on the Clinical Progression of Motor and Non-motor Features in Parkinson’s Disease","year":2009,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Population; Apathy; Dementia; Parkinson's disease; Disease; Movement disorders; Physical medicine and rehabilitation; Depression (economics); Cognition; Psychiatry; Internal medicine","score_opus":0.06602022239602924,"score_gpt":0.3802117149898312,"score_spread":0.31419149259380197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480287584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78879476,0.19954313,0.002072314,0.0008586615,0.00022097475,0.00015168481,0.0022495978,0.00005267213,0.0060562557],"genre_scores_gemma":[0.9299003,0.06680819,0.0007995602,0.00028114906,0.00014449393,0.000088088374,0.0015602568,0.0000062549457,0.00041179685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978275,0.0008609995,0.00030438675,0.0004918457,0.00045333602,0.00006195041],"domain_scores_gemma":[0.9944524,0.0027721121,0.0014886066,0.00035785756,0.0007897023,0.0001393878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044482676,0.00025713095,0.0012284665,0.0017600985,0.00019703485,0.00058029103,0.0004338643,0.0007061713,0.0012228738],"category_scores_gemma":[0.009515247,0.0002133356,0.0006089285,0.0023758633,0.0003824293,0.00045129406,0.00028827452,0.00049266603,0.00018828025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016641669,0.0003394865,0.7656159,0.002885902,0.005490039,0.0006706152,0.001071753,0.0013224819,0.0012544523,0.0005785341,0.0023018424,0.21680486],"study_design_scores_gemma":[0.000034472865,0.00052712904,0.9935002,0.00015152837,0.0008052632,0.0012311857,0.00018544991,0.00011695143,0.0001114936,0.00022444942,0.0030940792,0.000017720096],"about_ca_topic_score_codex":0.0018229792,"about_ca_topic_score_gemma":0.00210833,"teacher_disagreement_score":0.0044482676,"about_ca_system_score_codex":0.00031171227,"about_ca_system_score_gemma":0.00031285704,"threshold_uncertainty_score":0.02352494},"labels":[],"label_agreement":null},{"id":"W2481203324","doi":"10.17925/enr.2008.03.02.64","title":"Repetitive Transcranial Magnetic Stimulation as a Complementary Treatment for Post-stroke Aphasia","year":2008,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Spatial Neglect and Hemispheric Dysfunction","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transcranial magnetic stimulation; Medicine; Aphasia; Stroke (engine); Physical medicine and rehabilitation; Stimulation; Psychiatry; Internal medicine; Engineering","score_opus":0.0710531394806821,"score_gpt":0.3013187105866479,"score_spread":0.2302655711059658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481203324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019385773,0.9947824,0.00022103319,0.00035127543,0.00044855475,0.0000057795132,0.0000093881645,0.0000070031024,0.0022360252],"genre_scores_gemma":[0.01868076,0.97660893,0.0005196228,0.0012604054,0.0013461631,0.00003203119,0.000044722383,0.0000053840927,0.0015019592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997516,0.000060955892,0.00006511366,0.00004266326,0.000056465167,0.000023164353],"domain_scores_gemma":[0.9995994,0.00027607926,0.00005278158,0.000011220692,0.000045237677,0.000015294041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083234033,0.0006933001,0.001490659,0.0013648305,0.000277482,0.00061810104,0.00084118394,0.0016683708,0.0026685735],"category_scores_gemma":[0.0009374638,0.0001277827,0.00044218433,0.0012292004,0.000587576,0.0008896599,0.00028618617,0.00085215125,0.0009503337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074449944,0.00018892829,0.00035885233,0.012541468,0.00033158294,0.00317894,0.00007568884,0.00018010616,0.0063834484,0.0013755205,0.012688456,0.96195245],"study_design_scores_gemma":[0.000841705,0.0024521588,0.020205878,0.007221551,0.0017865084,0.10246342,0.0004861954,0.0005140274,0.007354393,0.0038019316,0.8527428,0.00012944263],"about_ca_topic_score_codex":0.00065546297,"about_ca_topic_score_gemma":0.0022156686,"teacher_disagreement_score":0.0026685735,"about_ca_system_score_codex":0.00041069387,"about_ca_system_score_gemma":0.00072605984,"threshold_uncertainty_score":0.008927226},"labels":[],"label_agreement":null},{"id":"W2482400956","doi":"10.17925/enr.2009.04.01.72","title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy - An Overview of Intravenous Immunoglobulin Therapy","year":2009,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Polyradiculoneuropathy; Placebo; Regimen; Intravenous Immunoglobulins; Maintenance therapy; Internal medicine; Antibody; Pediatrics; Immunology; Chemotherapy; Guillain-Barre syndrome; Pathology; Alternative medicine","score_opus":0.05286088149785559,"score_gpt":0.315881552259179,"score_spread":0.2630206707613234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482400956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033515666,0.9969836,0.00033191286,0.0006049228,0.00032515678,0.000011350201,0.00000955452,0.000010038426,0.0013883163],"genre_scores_gemma":[0.001209727,0.99677074,0.00051238766,0.00039833193,0.0005605835,0.000014653805,0.000019570512,0.0000021823914,0.00051184994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954516,0.00012762763,0.000083833496,0.000060531645,0.00014154467,0.000041197505],"domain_scores_gemma":[0.99964213,0.00017487968,0.000047112866,0.00000878179,0.00008526833,0.000041842275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010030312,0.00093168876,0.0016713025,0.0035995152,0.00032376256,0.0012164714,0.0008017432,0.0015993493,0.0016869748],"category_scores_gemma":[0.0007545635,0.00031030565,0.0005348254,0.0028855652,0.00053009705,0.0016278853,0.00053340115,0.0019429169,0.0013894142],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022276385,0.000309477,0.00075756066,0.0078059444,0.00013868918,0.0010912318,0.0000760212,0.0007207527,0.0013790904,0.0038856892,0.024123704,0.9594891],"study_design_scores_gemma":[0.00015855828,0.00078638183,0.0056213206,0.0092907855,0.0001912804,0.013846802,0.00017356241,0.0005710235,0.00054727675,0.0056178444,0.9631384,0.00005669167],"about_ca_topic_score_codex":0.0012352355,"about_ca_topic_score_gemma":0.002042725,"teacher_disagreement_score":0.0035995152,"about_ca_system_score_codex":0.0011610255,"about_ca_system_score_gemma":0.0009699631,"threshold_uncertainty_score":0.008423865},"labels":[],"label_agreement":null},{"id":"W2485697989","doi":"10.17925/enr.2012.07.01.10","title":"Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis - A Medical, Sociological and Media Controversy","year":2012,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple sclerosis; Medicine; Clinical trial; Skepticism; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.08131214355570238,"score_gpt":0.28661248805058737,"score_spread":0.205300344494885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485697989","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0091408705,0.20536552,0.00006913463,0.7692488,0.008728446,0.0000072364046,0.00007514504,0.000009933701,0.0073549235],"genre_scores_gemma":[0.20780174,0.295157,0.00026710393,0.39907622,0.09439715,0.00004469982,0.0001102161,0.000041486826,0.003104467],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9945986,0.0024516578,0.00042463746,0.0006242082,0.0012787441,0.00062217383],"domain_scores_gemma":[0.9652573,0.02435731,0.0035179798,0.00063890294,0.0030567711,0.0031718018],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.010356378,0.00038736349,0.0011014448,0.005188344,0.008443167,0.012443476,0.0014578328,0.012219091,0.0059596505],"category_scores_gemma":[0.026795905,0.00045302825,0.00058155955,0.0042804293,0.017879274,0.010941021,0.0050269733,0.012459981,0.0010638549],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041771203,0.00032291326,0.020343207,0.0035800652,0.00023247646,0.0057245106,0.061999653,0.000100100224,0.00070149614,0.1789237,0.4752089,0.25244528],"study_design_scores_gemma":[0.00013147082,0.0001590351,0.026072435,0.011844398,0.00018204987,0.008965249,0.051165603,0.00013403277,0.00021521574,0.04799536,0.85294074,0.00019451225],"about_ca_topic_score_codex":0.008513649,"about_ca_topic_score_gemma":0.009057176,"teacher_disagreement_score":0.9915568,"about_ca_system_score_codex":0.0062346854,"about_ca_system_score_gemma":0.0047101853,"threshold_uncertainty_score":0.05477041},"labels":[],"label_agreement":null},{"id":"W2487755826","doi":"10.17925/enr.2011.06.03.181","title":"Primary Angiitis of the Central Nervous System - Clinical Approaches, Challenges and Controversies","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Université de Montréal","keywords":"Medicine; Vasculitis; Headaches; Intensive care medicine; Central nervous system; Magnetic resonance imaging; Cerebral vasculitis; Pathology; Disease; Surgery; Radiology; Internal medicine","score_opus":0.15696103768357386,"score_gpt":0.25694419389438666,"score_spread":0.0999831562108128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487755826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072481576,0.95889217,0.00029161992,0.03649942,0.0018203984,0.000006871946,0.000016110993,0.00001746525,0.0017312323],"genre_scores_gemma":[0.016444316,0.9450756,0.0014830999,0.018423617,0.017692093,0.000037425594,0.000039555893,0.000012172694,0.0007921748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801457,0.00079229526,0.000376239,0.00024000763,0.00042969422,0.00014717154],"domain_scores_gemma":[0.99452716,0.0029518795,0.00046299974,0.00017659059,0.0013202352,0.0005610839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005753961,0.000907816,0.0024895556,0.002775733,0.0009952347,0.0031976767,0.0029012053,0.005569056,0.0022511543],"category_scores_gemma":[0.008148576,0.00037590184,0.00061404606,0.0023851355,0.0046239668,0.006888747,0.0017581717,0.00540458,0.001381716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028099166,0.0002673845,0.005294004,0.013524058,0.00024438568,0.014483189,0.0006768848,0.000754107,0.0008994529,0.031388633,0.14806278,0.7841242],"study_design_scores_gemma":[0.0002409402,0.00041919528,0.013270157,0.030741012,0.0003593191,0.11320144,0.0073382505,0.0012336661,0.00062167924,0.09733082,0.7349811,0.00026245008],"about_ca_topic_score_codex":0.0018981501,"about_ca_topic_score_gemma":0.005052341,"teacher_disagreement_score":0.005753961,"about_ca_system_score_codex":0.0024991182,"about_ca_system_score_gemma":0.0032018134,"threshold_uncertainty_score":0.030430257},"labels":[],"label_agreement":null},{"id":"W2493461058","doi":"10.17925/enr.2010.05.01.100","title":"nordic fMRI Solution - Products for Enhancing the Development of a Functional Imaging Clinical Practice","year":2010,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordic Life Science Pipeline (Canada)","funders":"","keywords":"Medicine; Neurosurgery; Functional magnetic resonance imaging; Magnetic resonance imaging; Medical physics; Plan (archaeology); Clinical Practice; Radiology; Physical therapy","score_opus":0.08123079722976215,"score_gpt":0.3651654960492344,"score_spread":0.2839346988194722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493461058","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053004522,0.09859277,0.3433732,0.023326004,0.007682152,0.0028356302,0.0020101024,0.00911131,0.46006423],"genre_scores_gemma":[0.085734226,0.027662795,0.7663078,0.0036175551,0.0010728898,0.0012198793,0.0014037174,0.00165839,0.11132287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797016,0.00060876156,0.00019684741,0.00027604148,0.00085450854,0.0000935542],"domain_scores_gemma":[0.9948655,0.0016212891,0.00036908215,0.00031100647,0.002042331,0.00079078635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007804917,0.0005975492,0.00039174798,0.002088143,0.000447508,0.001576221,0.0007305086,0.0018127987,0.021696316],"category_scores_gemma":[0.008836023,0.00035602652,0.00032358916,0.00065360527,0.0007192396,0.001333791,0.0015809361,0.0008431797,0.0102753695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044999324,0.00027910835,0.002199987,0.0010638026,0.000029085144,0.0011656386,0.0007328676,0.00061785546,0.040351856,0.02192665,0.06723475,0.86394846],"study_design_scores_gemma":[0.00018080485,0.00041371174,0.0044153123,0.00073170895,0.000038136524,0.0042771315,0.00021706516,0.001227733,0.0150473565,0.0053489106,0.9680521,0.000050041628],"about_ca_topic_score_codex":0.0010606686,"about_ca_topic_score_gemma":0.0022899867,"teacher_disagreement_score":0.021696316,"about_ca_system_score_codex":0.00082079554,"about_ca_system_score_gemma":0.003639658,"threshold_uncertainty_score":0.07258147},"labels":[],"label_agreement":null},{"id":"W2493501087","doi":"10.17925/enr.2014.09.02.156","title":"Erratum to: Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease","year":2015,"lang":"en","type":"erratum","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Parkinson's disease; Psychological intervention; Disease; Quality of life (healthcare); Intensive care medicine; Gerontology; Physical medicine and rehabilitation; Psychiatry; Nursing; Internal medicine","score_opus":0.11182651970124827,"score_gpt":0.3825397898921499,"score_spread":0.27071327019090163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493501087","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012556619,0.056196287,0.00018281607,0.054555785,0.8854627,0.00006920999,0.00076877186,0.000048005917,0.002590907],"genre_scores_gemma":[0.007007555,0.22830436,0.0030981933,0.26767632,0.407821,0.00053944805,0.0025184671,0.00027247294,0.08276225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606127,0.0006898348,0.0013527671,0.0002940889,0.0013891427,0.00021288733],"domain_scores_gemma":[0.9830578,0.0066658463,0.0017210798,0.00043385997,0.0076082586,0.0005131296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054565105,0.001994052,0.0035147402,0.003156856,0.0013414224,0.0026981004,0.0022971074,0.006371445,0.027086074],"category_scores_gemma":[0.04279781,0.000947137,0.0031895358,0.0023856142,0.0014431505,0.0020464542,0.0014449058,0.0075065335,0.013052793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491895,0.00001605104,0.000067832385,0.0024866173,0.00007536813,0.00014809245,0.000018491855,0.000031952648,0.000034029315,0.0004952969,0.97732794,0.019149024],"study_design_scores_gemma":[0.00046020257,0.00014833527,0.001752435,0.009959497,0.00075103797,0.00069138367,0.000100116864,0.00010242842,0.00025905555,0.0011653968,0.9845508,0.00005939528],"about_ca_topic_score_codex":0.012097285,"about_ca_topic_score_gemma":0.016912408,"teacher_disagreement_score":0.027086074,"about_ca_system_score_codex":0.0033376224,"about_ca_system_score_gemma":0.0066022538,"threshold_uncertainty_score":0.090611935},"labels":[],"label_agreement":null},{"id":"W2496454534","doi":"10.17925/enr.2008.03.01.14","title":"Rivastigmine in the Treatment of Alzheimer’s Disease and Parkinson’s Disease Dementia","year":2008,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Alzheimer Society","keywords":"Rivastigmine; Medicine; Dementia; Disease; Parkinson's disease; Donepezil; Psychiatry; Internal medicine","score_opus":0.10494822346310924,"score_gpt":0.3201595608090969,"score_spread":0.21521133734598769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496454534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042647222,0.99781114,0.00004650237,0.00036542793,0.00018700607,0.000004935259,0.000009196503,0.000004089043,0.001145266],"genre_scores_gemma":[0.0060778,0.9911311,0.00019667354,0.0006010596,0.00056202983,0.000012987375,0.000031498417,0.0000022051593,0.0013845072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948657,0.00019242521,0.000067724926,0.000043871187,0.00016898446,0.000040512736],"domain_scores_gemma":[0.99975747,0.000085528205,0.00006169007,0.0000057695183,0.000060617294,0.00002884187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011361283,0.00060173817,0.001485293,0.0012435361,0.00026474622,0.00050909363,0.0006910546,0.0012062697,0.002237883],"category_scores_gemma":[0.0010543278,0.0001486042,0.0004832006,0.0010915046,0.00026769328,0.00059500884,0.00029388122,0.0010928154,0.0013402432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076051836,0.00018220302,0.0004733226,0.009196561,0.00020273594,0.0016181866,0.000076377204,0.000394342,0.0019375229,0.0016520912,0.0448519,0.9386543],"study_design_scores_gemma":[0.0008421374,0.0013199836,0.0067584706,0.004566891,0.00043770584,0.014000852,0.00011163058,0.0001980337,0.0010341865,0.0027238142,0.9679702,0.000036155565],"about_ca_topic_score_codex":0.00173083,"about_ca_topic_score_gemma":0.0036725071,"teacher_disagreement_score":0.002237883,"about_ca_system_score_codex":0.0005242609,"about_ca_system_score_gemma":0.00080344325,"threshold_uncertainty_score":0.0074864626},"labels":[],"label_agreement":null},{"id":"W2498212039","doi":"10.17925/enr.2011.06.01.31","title":"Measuring Disability Progression with the Multiple Sclerosis Functional Composite","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Expanded Disability Status Scale; Medicine; Physical medicine and rehabilitation; Multiple sclerosis; Physical therapy; Quality of life (healthcare); Psychiatry","score_opus":0.33925592390060133,"score_gpt":0.31407797776244883,"score_spread":0.025177946138152496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498212039","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42120716,0.48436382,0.012572917,0.0028602423,0.0012015828,0.0020279342,0.01631765,0.00043732816,0.05901131],"genre_scores_gemma":[0.8438311,0.11565263,0.022677686,0.0008860025,0.0006934452,0.0012590124,0.008726977,0.000027499987,0.0062455437],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979747,0.0006768362,0.00028190226,0.00019835663,0.0007987523,0.000069412454],"domain_scores_gemma":[0.997045,0.0007785172,0.0010212522,0.00007869467,0.0009400625,0.0001365252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046429057,0.0005337129,0.0010464401,0.003630154,0.00026571675,0.0005937877,0.00046570756,0.00034456744,0.0018795521],"category_scores_gemma":[0.0046137613,0.000093571296,0.00084393047,0.0027760987,0.00023965808,0.000498968,0.0005127635,0.00068700087,0.00034529204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023104767,0.0005112915,0.30999622,0.0071485904,0.00366787,0.00016921833,0.00041346182,0.0014958573,0.0017325314,0.002096606,0.021828704,0.64862925],"study_design_scores_gemma":[0.00024792238,0.0024302828,0.9439844,0.0016591409,0.0017289395,0.0014860993,0.00021173028,0.0011307115,0.0020742852,0.0017374867,0.043223873,0.00008501665],"about_ca_topic_score_codex":0.005040541,"about_ca_topic_score_gemma":0.007850691,"teacher_disagreement_score":0.005040541,"about_ca_system_score_codex":0.000853867,"about_ca_system_score_gemma":0.00082686293,"threshold_uncertainty_score":0.024554312},"labels":[],"label_agreement":null},{"id":"W2498961769","doi":"10.17925/enr.2011.06.03.170","title":"Stroke Rehabilitation - An Overview of Existing Guidelines and Standards of Care","year":2011,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rehabilitation; Medicine; Stroke (engine); Guideline; Best evidence; Health care; MEDLINE; Physical therapy; Intensive care medicine; Pathology","score_opus":0.25730854178400586,"score_gpt":0.422859742719189,"score_spread":0.16555120093518316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498961769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018366487,0.90881366,0.009999238,0.051531512,0.0036081302,0.00203862,0.0026699859,0.00033774375,0.019164488],"genre_scores_gemma":[0.011194653,0.89953804,0.067399815,0.010660981,0.0009243324,0.0025444904,0.0052513382,0.00014209517,0.0023441557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9710616,0.009028794,0.010837112,0.0008655116,0.0073845084,0.0008224779],"domain_scores_gemma":[0.96966875,0.009598561,0.0042759147,0.0007682486,0.01474526,0.0009433483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028997798,0.0015891138,0.003457566,0.014398722,0.0019065848,0.0053036804,0.006296698,0.004770631,0.0047299424],"category_scores_gemma":[0.053672735,0.0011673094,0.0027288261,0.021322671,0.0014239419,0.0047028386,0.0028321445,0.005047897,0.0028968307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012940964,0.00023958123,0.0023654434,0.051541466,0.00041655038,0.00034415998,0.0010890029,0.0011886861,0.0003483952,0.012234407,0.18749405,0.7426087],"study_design_scores_gemma":[0.00013531916,0.00017062231,0.0072404365,0.24953008,0.0010269976,0.000983047,0.0016956541,0.00080841104,0.00035328622,0.009525684,0.7284039,0.00012652841],"about_ca_topic_score_codex":0.023986094,"about_ca_topic_score_gemma":0.05413426,"teacher_disagreement_score":0.028997798,"about_ca_system_score_codex":0.011100746,"about_ca_system_score_gemma":0.034362517,"threshold_uncertainty_score":0.15335685},"labels":[],"label_agreement":null},{"id":"W2500149517","doi":"10.17925/enr.2014.09.01.19","title":"Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease","year":2014,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; Rasagiline; Entacapone; Parkinson's disease; Quality of life (healthcare); Clinical trial; Disease; Selegiline; Levodopa; Physical therapy; Internal medicine","score_opus":0.08007996613588365,"score_gpt":0.369704069017225,"score_spread":0.2896241028813414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500149517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9025128,0.08895218,0.0002336198,0.0009393394,0.00047438152,0.00043595966,0.00051432324,0.000034589568,0.0059027625],"genre_scores_gemma":[0.9812501,0.016477797,0.00055939617,0.00030188414,0.00021724,0.0003228601,0.00032223968,0.0000043903237,0.000544182],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988269,0.00072733895,0.00011197535,0.000095652176,0.00014207241,0.00009607858],"domain_scores_gemma":[0.99877614,0.0007293211,0.00023191296,0.000037058788,0.00005893829,0.0001665518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012437867,0.0004620223,0.0016023299,0.00046283915,0.00029484942,0.00036830266,0.00030344113,0.00054836296,0.0034563523],"category_scores_gemma":[0.0025944146,0.00011323901,0.001857532,0.00036750195,0.00031118584,0.0003470461,0.00038639663,0.0010169311,0.00016890574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32481435,0.045307867,0.011244743,0.011786478,0.011573085,0.00023891852,0.0004317742,0.0020712388,0.005555401,0.00086379633,0.002353923,0.5837584],"study_design_scores_gemma":[0.10929702,0.4167494,0.4344329,0.0033660883,0.013490969,0.00042891598,0.0005606908,0.0032051648,0.0036289205,0.002363941,0.012378675,0.000097299],"about_ca_topic_score_codex":0.00076496165,"about_ca_topic_score_gemma":0.0009949052,"teacher_disagreement_score":0.0034563523,"about_ca_system_score_codex":0.0004594283,"about_ca_system_score_gemma":0.00036132763,"threshold_uncertainty_score":0.011562645},"labels":[],"label_agreement":null},{"id":"W2780149296","doi":"10.17925/enr.2017.12.02.64","title":"Preventative Therapies for Migraine","year":2017,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Migraine; Intensive care medicine; Physical medicine and rehabilitation; Anesthesia","score_opus":0.12192867107125539,"score_gpt":0.4094433864359532,"score_spread":0.2875147153646978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780149296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009830856,0.9914125,0.000061563296,0.0044061067,0.0011744717,0.000008501598,0.000020919666,0.0000045365605,0.002812989],"genre_scores_gemma":[0.0016275697,0.9888515,0.00022429132,0.005580955,0.0012257026,0.000016133105,0.000039326285,0.0000030060958,0.0024315198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987563,0.00045526423,0.00016383182,0.0000761543,0.00045961273,0.00008885696],"domain_scores_gemma":[0.99837154,0.0010591688,0.00015084894,0.000041757856,0.00032805934,0.00004878018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002328529,0.00049405737,0.0006683382,0.0018012414,0.0005370452,0.0012441499,0.0005178267,0.001595862,0.008676856],"category_scores_gemma":[0.004707814,0.00016877164,0.00082149863,0.0010843219,0.00075850415,0.0015197246,0.0008637724,0.002577293,0.0019984553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015110895,0.000068465844,0.00021262276,0.015436878,0.00012633864,0.00014322871,0.00022663252,0.00006986697,0.00074359606,0.015413268,0.2162518,0.7511563],"study_design_scores_gemma":[0.000037322134,0.000070402726,0.00070516526,0.008572593,0.00007059784,0.0005187448,0.00009299313,0.000012242726,0.00013072364,0.00238702,0.98739326,0.000008918638],"about_ca_topic_score_codex":0.003322818,"about_ca_topic_score_gemma":0.007872319,"teacher_disagreement_score":0.008676856,"about_ca_system_score_codex":0.0011385573,"about_ca_system_score_gemma":0.0021909873,"threshold_uncertainty_score":0.029026985},"labels":[],"label_agreement":null},{"id":"W2902148099","doi":"10.17925/enr.2018.13.2.103","title":"Management of Migraine and the Accessibility of Specialist Care – Findings from a Multi-national Assessment of 28 Healthcare Networks","year":2018,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharma","keywords":"Migraine; Medicine; Referral; Triage; Specialty; Consistency (knowledge bases); Health care; Best practice; Delegation; Family medicine; Nursing; Medical emergency; Psychiatry","score_opus":0.07544529581554045,"score_gpt":0.3944507385794751,"score_spread":0.31900544276393467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902148099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902356,0.00012004365,0.000055588433,0.00014803323,0.0000024907922,0.000025710415,0.00014937721,0.0000012151975,0.00047399083],"genre_scores_gemma":[0.999387,0.00018626577,0.000118065545,0.000059754988,0.0000032708404,0.000033273885,0.00014129787,0.000001303103,0.00006982456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721366,0.0013582993,0.00040463635,0.00026588098,0.00039043248,0.0003671895],"domain_scores_gemma":[0.98694104,0.00447436,0.0058847787,0.00045654745,0.0010535037,0.0011898031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003894919,0.00016951385,0.00028452446,0.0012529405,0.0010461385,0.0015384743,0.00069928257,0.00054885267,0.0010614055],"category_scores_gemma":[0.01385016,0.00034235627,0.00045927175,0.001914559,0.0008151414,0.0020769928,0.0030288196,0.0006243507,0.0001427639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004717531,0.00006922699,0.980497,0.00010112844,0.00004455272,0.0002070755,0.014448916,0.00013416214,0.000100238256,0.00007173468,0.00023297915,0.0040458865],"study_design_scores_gemma":[0.0000051656616,0.00011891609,0.9665028,0.00009939403,0.000022288083,0.00035527238,0.03173757,0.0003687847,0.000040026793,0.00003191622,0.00070619525,0.000011714567],"about_ca_topic_score_codex":0.033127226,"about_ca_topic_score_gemma":0.0468092,"teacher_disagreement_score":0.033127226,"about_ca_system_score_codex":0.0022543373,"about_ca_system_score_gemma":0.0019096804,"threshold_uncertainty_score":0.065868795},"labels":[],"label_agreement":null},{"id":"W2962988692","doi":"10.17925/enr.2019.14.1.44","title":"Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy – Neurologist, Nursing and Patient Perspectives","year":2019,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Grifols; GBS/CIDP Foundation International; Argenx; Biogen; Union Chimique Belge; Sanofi; Alnylam Pharmaceuticals; Pfizer; CSL Behring; Myasthenia Gravis Foundation of America","keywords":"Chronic inflammatory demyelinating polyneuropathy; Medicine; Polyneuropathy; Physical medicine and rehabilitation; Antibody; Physical therapy; Immunology; Internal medicine","score_opus":0.010185562298052342,"score_gpt":0.2553008263591872,"score_spread":0.24511526406113487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962988692","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074070244,0.9807612,0.00006572748,0.008622281,0.003670646,0.0000021493308,0.000009112125,0.000005817889,0.006122381],"genre_scores_gemma":[0.013155245,0.9518208,0.00022702797,0.018409446,0.01267335,0.000011900554,0.000035677684,0.000004792652,0.0036617334],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9996538,0.00011976776,0.00006188042,0.000028833987,0.00008862422,0.000047073714],"domain_scores_gemma":[0.9989003,0.0006710447,0.000108244436,0.00001914728,0.00021461074,0.00008670685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001041084,0.0003451135,0.00063566846,0.0007546444,0.00026091232,0.0010098052,0.0007163805,0.0024673245,0.0025023],"category_scores_gemma":[0.0018063498,0.000087007924,0.00030311788,0.0008732674,0.0005845382,0.00094853545,0.00038249567,0.002044199,0.0013794203],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029645307,0.00014199252,0.0013763877,0.0061587105,0.000101048405,0.0066844043,0.00018189703,0.00019818988,0.00096656894,0.0046336656,0.2788846,0.70037603],"study_design_scores_gemma":[0.00016868782,0.00042723567,0.01273217,0.012888212,0.00015907381,0.042046506,0.0005512977,0.0001277771,0.00033721208,0.0022677695,0.92825806,0.000036038917],"about_ca_topic_score_codex":0.0018436996,"about_ca_topic_score_gemma":0.004777083,"teacher_disagreement_score":0.0025023,"about_ca_system_score_codex":0.0005392023,"about_ca_system_score_gemma":0.000977179,"threshold_uncertainty_score":0.0083709955},"labels":[],"label_agreement":null},{"id":"W3005819287","doi":"10.17925/enr.2019.14.2.73","title":"Ozanimod in Multiple Sclerosis","year":2019,"lang":"en","type":"article","venue":"European Neurological Review","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"Juno Therapeutics; Ontario Institute for Regenerative Medicine; Hospital for Sick Children; Multiple Sclerosis Society; Alexion Pharmaceuticals; F. Hoffmann-La Roche; Stem Cell Network; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Physical medicine and rehabilitation; Psychiatry","score_opus":0.043578448185137245,"score_gpt":0.2380263955032357,"score_spread":0.19444794731809845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005819287","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020711794,0.936092,0.000625852,0.015186434,0.01620196,0.000020374853,0.00018223285,0.0000901283,0.029529732],"genre_scores_gemma":[0.019992718,0.9023493,0.00090697216,0.023500953,0.019388286,0.00007377581,0.00045382374,0.000040889503,0.03329322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999082,0.000014461779,0.000013447568,0.000012405078,0.00003464836,0.000016784054],"domain_scores_gemma":[0.9999089,0.000028772607,0.000016431124,0.000005339531,0.00002185538,0.000018643688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030049228,0.00049898395,0.0004851875,0.00052523124,0.00023508472,0.00061251986,0.0006262709,0.0014707434,0.007959894],"category_scores_gemma":[0.0003487118,0.00007686977,0.00033984907,0.000564991,0.0005074859,0.0006913514,0.0007086837,0.0015258582,0.004136032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073158636,0.00005661821,0.0002085349,0.0026208537,0.00007030584,0.0017263901,0.00001956464,0.000107475586,0.0028534937,0.0069084917,0.23438098,0.7503157],"study_design_scores_gemma":[0.00014109183,0.00014895193,0.0011039533,0.00059058564,0.000067858644,0.002719369,0.000021462796,0.00004007278,0.0010111512,0.0018014188,0.99234277,0.000011308158],"about_ca_topic_score_codex":0.00058756483,"about_ca_topic_score_gemma":0.0011882405,"teacher_disagreement_score":0.007959894,"about_ca_system_score_codex":0.0003589246,"about_ca_system_score_gemma":0.0005560441,"threshold_uncertainty_score":0.026628554},"labels":[],"label_agreement":null}]}